Presentation ACC 2024 A Selective Aldose Reductase Inhibitor for the Treatment of Diabetic Cardiomyopathy Presenter: James L. Januzzi Jr April 08, 2024 REGISTER for free or LOG IN to view this content Diabetes Heart Failure Presentation ACC 2024 Up Next Presentation ACC 2024 Evaluation of a Technology Assisted Web Application to Qualify for Nonprescription Statin Administration Presenter: Steven E. Nissen April 08, 2024 More slides + Presentation ACC 2024 PROACT: Can we prevent chemotherapy-related heart damage in patients with breast cancer and lymphoma? Presenter: David Austin April 08, 2024 Presentation ACC 2024 Topical Tranexamic Acid to Reduce Seizures in Cardiac Surgery Presenter: Andre Lamy April 08, 2024 We Recommend
Presentation ACC 2024 Evaluation of a Technology Assisted Web Application to Qualify for Nonprescription Statin Administration Presenter: Steven E. Nissen April 08, 2024
Presentation ACC 2024 PROACT: Can we prevent chemotherapy-related heart damage in patients with breast cancer and lymphoma? Presenter: David Austin April 08, 2024
Presentation ACC 2024 Topical Tranexamic Acid to Reduce Seizures in Cardiac Surgery Presenter: Andre Lamy April 08, 2024